These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2908236)

  • 1. Prevalence of obesity in patients receiving depot antipsychotics.
    Silverstone T; Smith G; Goodall E
    Br J Psychiatry; 1988 Aug; 153():214-7. PubMed ID: 2908236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroleptic effects on platelet aggregation: a study in normal volunteers and schizophrenics.
    Dinan TG
    Psychol Med; 1987 Nov; 17(4):875-81. PubMed ID: 2893407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depot flupenthixol decanoate for schizophrenia or other similar psychotic disorders.
    Quraishi S; David A
    Cochrane Database Syst Rev; 2000; (2):CD001470. PubMed ID: 10796442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Weight gain associated with antipsychotic drugs.
    Ganguli R
    J Clin Psychiatry; 1999; 60 Suppl 21():20-4. PubMed ID: 10548138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ten year outcomes of outpatients with schizophrenia on conventional depot antipsychotics: a systematic chart review.
    Uchida T; Suzuki T; Sakurai H; Tsutsumi C; Den R; Mimura M; Uchida H
    Int Clin Psychopharmacol; 2013 Sep; 28(5):261-6. PubMed ID: 23820334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Weight changes with depot neuroleptic maintenance therapy.
    Johnson DA; Breen M
    Acta Psychiatr Scand; 1979 May; 59(5):525-8. PubMed ID: 463589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of schizophrenia with depot preparations of fluphenazine, haloperidol, and risperidone among inpatients at state-operated psychiatric facilities.
    Citrome L; Jaffe A; Levine J
    Schizophr Res; 2010 Jun; 119(1-3):153-9. PubMed ID: 20347267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of tardive dyskinesia in patients receiving depot neuroleptic injection.
    Gibson AC
    Acta Psychiatr Scand Suppl; 1981; 291():111-6. PubMed ID: 6113729
    [No Abstract]   [Full Text] [Related]  

  • 9. Rationalizing neuroleptic polypharmacy in chronic schizophrenics: effects of changing to a single depot preparation.
    Soni SD; Sampath G; Shah A; Krska J
    Acta Psychiatr Scand; 1992 May; 85(5):354-9. PubMed ID: 1351333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depot injections and tardive dyskinesia.
    Gibson AC
    Br J Psychiatry; 1978 Oct; 133():361-5. PubMed ID: 709010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Metabolic side effects of risperidone in early onset schizophrenia].
    Goeb JL; Marco S; Duhamel A; Kechid G; Bordet R; Thomas P; Delion P; Jardri R
    Encephale; 2010 Jun; 36(3):242-52. PubMed ID: 20620267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intramuscular preparations of antipsychotics: uses and relevance in clinical practice.
    Altamura AC; Sassella F; Santini A; Montresor C; Fumagalli S; Mundo E
    Drugs; 2003; 63(5):493-512. PubMed ID: 12600227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy with neuroleptics. Clinical and pharmacokinetic aspects with a particular view to depot preparations.
    Knudsen P
    Acta Psychiatr Scand Suppl; 1985; 322():51-75. PubMed ID: 2866666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depot bromperidol decanoate for schizophrenia.
    Wong D; Adams CE; David A; Quraishi SN
    Cochrane Database Syst Rev; 2004; (3):CD001719. PubMed ID: 15266450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of antipsychotic depot injections in the maintenance treatment of schizophrenia.
    Carney MW; Sheffield BF
    Br J Psychiatry; 1976 Nov; 129():476-81. PubMed ID: 990663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depot fluphenazine for schizophrenia.
    Adams CE; Eisenbruch M
    Cochrane Database Syst Rev; 2000; (2):CD000307. PubMed ID: 10796340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depot fluphenazine decanoate and enanthate for schizophrenia.
    David A; Adams CE; Eisenbruch M; Quraishi S; Rathbone J
    Cochrane Database Syst Rev; 2005 Jan; (1):CD000307. PubMed ID: 15674872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bromperidol decanoate (depot) for schizophrenia.
    Purgato M; Adams CE
    Cochrane Database Syst Rev; 2011 Sep; (9):CD001719. PubMed ID: 21901678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tardive dyskinesia in outpatients on depot phenothiazine.
    Neehall J
    West Indian Med J; 1989 Dec; 38(4):228-33. PubMed ID: 2576166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-acting injectable formulations of antipsychotic drugs for the treatment of schizophrenia.
    Park EJ; Amatya S; Kim MS; Park JH; Seol E; Lee H; Shin YH; Na DH
    Arch Pharm Res; 2013 Jun; 36(6):651-9. PubMed ID: 23543652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.